|
Powered by Cell Signaling Technology |
Site Information |
---|
DLIMKEDyELVSTkP SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 4270705 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on RIPK2: | |
Effects of modification on biological processes: | |
Induce interaction with: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Ellwanger K, et al. (2019) XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures. Life Sci Alliance 2
31350258 Curated Info |
|
Shehat MG, et al. (2019) RIP2 promotes FcγR-mediated reactive oxygen species production. J Biol Chem 294, 10365-10378
31113864 Curated Info |
|
Mayle S, et al. (2014) Engagement of Nucleotide-binding Oligomerization Domain-containing Protein 1 (NOD1) by Receptor-interacting Protein 2 (RIP2) Is Insufficient for Signal Transduction. J Biol Chem 289, 22900-14
24958724 Curated Info |
|
Rahman MA, et al. (2014) Receptor interacting protein-2 plays a critical role in human lung epithelial cells survival in response to fas-induced cell-death. PLoS One 9, e92731
24658576 Curated Info |
|
Tigno-Aranjuez JT, Asara JM, Abbott DW (2010) Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev 24, 2666-77
21123652 Curated Info |